Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Related Posts
X CEO Linda Yaccarino Contends With Pitfalls of Sharing Power With Elon Musk
Tensions over the division of labor with Musk have stymied some of Yaccarino’s initiatives.
Shell, BP and TotalEnergies Invest in Major Abu Dhabi LNG Project
European energy giants Shell, BP and TotalEnergies have signed deals to invest in Abu Dhabi’s Ruwais liquefied natural-gas project, set to boost the Gulf nation’s […]
Casino Operator Star Reports Annual Loss Amid Liquidity, Regulatory Squeezes
Star Entertainment reported a massive annual loss in its delayed results as the embattled Australian casino owner moves to shore up its balance sheet and […]